RSS

MSD

A new community launched for women working in the supply chain has attracted major pharma company MSD as one of its founding sponsors. Read more

News

The European Commission (EC) has granted a marketing authorisation for the oral receptor tyrosine kinase (RTK) inhibitor, LENVIMA (lenvatinib mesylate), as first-line treatment for adults with advanced or unresectable hepatocellular carcinoma (HCC). Read more

News

A label change for MSD’s (known as Merck in the US and Canada) ulcerative colitis (UC) treatment — SIMPONI (golimumab) — has received approval from the European Commission. Read more

News

As part of the launch of the British government’s industrial strategy for safeguarding the UK economy post-Brexit, it has announced a multi-billion pound sector deal designed to boost the nation’s life science sector. Read more

News

Ahead of the government’s announcement of its industrial strategy, it has been revealed that MSD (also known as Merck) will make a landmark investment into the UK’s economy through the opening of a new UK hub, for the research into future treatments. Read more

News

sanofi.jpg

360b / Shutterstock.com

In two separate press statements, Sanofi announced it has concluded its business swap with Boehringer Ingelheim, and has also closed its European vaccines joint venture with MSD (Merck & Co.). Read more

News

Abbvie, Sanofi and Novo Nordisk seens as most reputable pharma companies in the UK and industry as a whole ranked third most reputable by general public Read more

News

Sanofi Pasteur and MSD, known as Merck in the US, announced their intent to end their joint vaccines operations in Europe Read more

News